Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Correvio Pharma Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Correvio Pharma Corp market cap is $27.79M.
What is the 52-week high for Correvio Pharma Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Correvio Pharma Corp 52 week high is $2.79 as of September 16, 2025.
What is the 52-week low for Correvio Pharma Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Correvio Pharma Corp 52 week low is $0.21 as of September 16, 2025.
What is Correvio Pharma Corp stock price today?
Correvio Pharma Corp stock price today is $0.4199.
What was Correvio Pharma Corp stock price yesterday?
Correvio Pharma Corp stock price yesterday was $0.4165.
What is the PE ratio of Correvio Pharma Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Correvio Pharma Corp’s P/E ratio is -0.51.
What is the Price-to-Book ratio of Correvio Pharma Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Correvio Pharma Corp P/B ratio is -27.8818.
What is the 50-day moving average of Correvio Pharma Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Correvio Pharma Corp 50-day moving average is $0.3873.
